article information

Nephro-Urology Monthly: Vol.5, issue 1; 683-686
published online: December 15, 2012
article type: Research Article
received: April 8, 2012
revised: May 12, 2012
accepted: May 19, 2012
DOI: https://doi.org/10.5812/numonthly.5055
Crossmark

Effects of High Versus Low Flux Membranes on O2 Saturation in Hemodialysis Patients

authors:

avatar Ali Momeni 1 , * , avatar Hamid Rouhi 1 , avatar Masoud Amiri 2

Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
Social Health Determinants Research Center and Department of Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, IR Iran

how to cite: Momeni A, Rouhi H, Amiri M. Effects of High Versus Low Flux Membranes on O2 Saturation in Hemodialysis Patients. Nephro-Urol Mon. 2013;5(1): 683-686. https://doi.org/10.5812/numonthly.5055.

Abstract

Background:

Several studies have been carried out to evaluate the effects of dialysis on O2 saturation. While the dialysis procedure may lead to hypoxia under different circumstances, there are few studies available on the effects of membrane type on O2 saturation in these patients.

objectives:

This study was to appraise the effects of high and low flux membrane on pulse oxymetery in dialysis patients.

Patients and Methods:

In a cross-sectional evaluation, 43 hemodialysis patients without pulmonary disease were enrolled. Of this group, dialysis was performed by low and high flux membranes, and pulse oxymetery was applied before and after the procedures.

Results:

Mean age of the patients was 56.34 years. Of these patients, 23 (53.5%) and 20 (46.5%) were women and men, respectively. Type of membrane (high flux vs. low flux) did not show any significant effect on pulse oxymetery results (P > 0.05).

Conclusions:

Due to the lack of a significant difference in pulse oxymetery and creation of hypoxia between two types of membranes in hemodialysis patients, as well as the high cost of high flux membrane as compared to the low flux membrane, we do not suggest the use of high flux membrane in dialysis.

1. Background

Low flux or high flux membranes can be applied for hemodialysis. High-flux dialysis is defined as a β2-microglobulin clearance of over 20 mL/min (1, 2). High flux membranes compared to low flux have larger pores and allow the diffusing of a greater amount of uremic toxins and middle molecules such as β2-microglobuline and may, therefore, decrease the risk of dialysis-related amyloidosis (3, 4). In addition, these membranes have other advantages such as increasing patients’ survival (5, 6), reduced admission and morbidity (7, 8), fewer activations of the coagulation pathway and complement system, lower leukocytosis, fewer activations of inflammatory system and less cytokines secretion, removal of more endotoxines, better lipid profile (9, 10), reduced infection risk, aluminum toxicity and better preserved renal function (11, 12).

Furthermore, intradialysis hypoxia was reported in former studies (13-15). Although the cause of this hypoxia is not completely clear, sequestration of leukocytes in pulmonary capillary may play an important role (16). The type of buffer used in dialysis also may be important in hypoxia (17, 18).

2. Objectives

As far as our knowledge, there is no study about the relationship between the type of hemodialysis membrane (high flux versus low flux) and hypoxia. Since high flux membranes are more permeable than low flux membrane, they might be responsible for the changes in O2 pressure and saturation in a dialysis session. The objective of our study was the evaluation of this relationship.

3. Patients and Methods

In a cross-sectional study, 43 volunteer hemodialysis patients were enrolled from June to December 2009 at Hajar hospital in Shahrekord, Iran. Inclusion criteria were age more than 18 years and duration of dialysis more than 6 months. Exclusion criteria were individuals who were non-cooperation during study, history of pulmonary disease and need for oxygen during dialysis.

The dialysis was performed using two types of membranes. While pulse oxymetery performed before and after dialysis with a low flux membrane, in the next dialysis session, pulse oxymetery was repeated in the same patients with a high flux membrane. Pulse oxymetery was done by Mir instrument (Italy). Dialysis by Ferezinius and Gambro digital machines (USA), 2 to 3 times per week, as a regular method (4 hours with blood flow (QB) of 250 to 350 mL/min, dialysate flow (QD) of 500 ml/min and ultra filtration based on the patients’ condition) had been performed. Chi-square and t-student tests according to quantitative of qualitative nature of variables, and also Pearson correlation to find our potential correlations, by using SPSS (version 19) had been used.

4. Results

Table 1 summarizes the results of our study. Out of 43 dialysis patients, twenty three were women (53.5%). The causes of renal failure were diabetes mellitus, hypertension, hereditary kidney disease and proteinuria in 23, 14, 3, and 3 patients, respectively. Ischemic heart disease was observed in 23 patients and three cases had congestive heart failure. Mean age of the patients was 56.34 years (ranged 23 to 84). While the weight of the patients before and after dialysis with a low flux membrane were 62.5 and 59.8 kilograms respectively (P < 0.001), the weight of patients before and after dialysis with a high flux membrane was 61.9 and 59.5 kilograms respectively (P < 0.001).

Table 1

Comparison of Variables of Patients With High and Low Flux Membrane After Dialysis

 Membrane TypeMeanStandard DeviationP
Body weight before dialysis, kg   0.8
 Low flux62.512.3 
 High flux61.912.5 
Body weight after dialysis, kg   0.9
 Low flux59.812.1 
 High flux59.512.1 
Diastolic blood pressure before dialysis, mmHg   0.15
 Low flux73.19.1 
 High flux75.98 
Diastolic blood pressure after dialysis, mmHg   0.7
 Low flux73.99 
 High flux73.29.1 
Systolic blood pressure before dialysis, mmHg   0.3
 Low flux125.511.5 
 High flux129.512.5 
Systolic blood pressure after dialysis, mmHg   0.7
 Low flux121.315.8 
 High flux1199.8 
O2 saturation before dialysis   0.3
 Low flux93.92.6 
 High flux953.8 
O2 saturation after dialysis   0.1
 Low flux93.23.7 
 High flux93.42.9 

Blood pressure before and after dialysis with a low flux or a high flux membrane did not show statistically significant differences (P > 0.05). O2 saturation before dialysis with a low flux membrane was 92.3% and after dialysis was 93.2% (P = 0.2). Similarly, O2 saturation before and after dialysis with a high flux membrane was 95% and 94.4% respectively (P = 0.5). There was also no difference between O2 saturation with high flux and low flux membranes, before or after dialysis (P > 0.05).

5. Discussion

To our knowledge, this study is the first investigation on the relationship between types of hemodialysis membrane (high flux versus low flux) and hypoxia. There was no difference between oxygen saturation in hemodialysis’ patients with high flux and low flux membranes. Based on our results, there was not any advantage to the high versus the low flux membrane.

Several studies were conducted on hypoxia due to hemodialysis and its physiopathology (15-17), such as Habte (15) who reported hypoxia of the patients during dialysis, Kao (19) with reporting of decreasing permeability of respiratory membrane to oxygen but disappearing after dialysis. However, Dhakal suggested that intradialysis hypoxia could be continued even after dialysis (20). Yap also concluded that intra dialytic oxygen didn’t cause improvement of ventilation profile (21). Furthermore, Hunt reported that intradialytic hypoxia depended on the type of buffer in the dialysis procedure so if acetate was used as a buffer, the oxygen removed from dialysate and hypocapnia caused depression of the respiratory center and mild hypoxia, however, the increasing serum bicarbonate and central depression occurred in the bicarbonate buffer (15, 19). Pitcher also reported equivalent results and mild hypoxia especially in patients with respiratory disease (14).

The other factor that may cause hypoxia in dialysis is sequestration of leukocytes in pulmonary capillaries during the early part of the dialysis procedure. This effect was reported by Craddock and Fountain (17, 22). There are different findings about the relationship of leucopenia and hypoxia during dialysis. For example, Ralph showed leucopenia without hypoxia at beginning of a dialysis session. This leukopenia disappeared after 2 hours and may have been accompanied with reactive leukocytosis (23). Fawcett and Vaziri in their studies reported less hypoxia with biocompatible membranes versus old membranes (24, 25). Unlike the above results, Hakim showed that hypoxia during hemodialysis was not significant and that there was no difference between the use of cynthetic or cellulose membrane in this respect (26).

In conclusion, our results indicated that membrane type (high vs. low flux) has no effect on the development or severity of intradialysis hypoxia. Routinely, dialysis procedure in Hajar hospital is performed with low flux membrane. If a high flux membrane had been used for a longer period, pulse oxymetery results may have been different from patients with a low flux membrane therefore we do recommend larger and longer follow up studies with high flux membrane in hemodialysis patients.

Acknowledgements

References

  • 1.

    Cheung AK, Leypoldt JK. The hemodialysis membranes: a historical perspective, current state and future prospect. Semin Nephrol. 1997;17(3):196-213. [PubMed ID: 9165649].

  • 2.

    Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR. Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int. 1997;51(6):2013-7. [PubMed ID: 9186896]. https://doi.org/10.1038/ki.1997.274.

  • 3.

    Jadoul M. Dialysis-related amyloidosis: importance of biocompatibility and age. Nephrol Dial Transplant. 1998;13(Suppl 7):61-4. [PubMed ID: 9870440]. https://doi.org/10.1093/ndt/13.suppl_7.61.

  • 4.

    Chandran PK, Liggett R, Kirkpatrick B. Patient survival on PAN/AN69 membrane hemodialysis: a ten-year analysis. J Am Soc Nephrol. 1993;4(5):1199-204. [PubMed ID: 8305647].

  • 5.

    Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol. 1992;3(6):1227-37. [PubMed ID: 1477318].

  • 6.

    Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997;52(4):1096-101. [PubMed ID: 9328951]. https://doi.org/10.1038/ki.1997.434.

  • 7.

    Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int. 1996;50(2):566-70. [PubMed ID: 8840287]. https://doi.org/10.1038/ki.1996.350.

  • 8.

    Churchill DN. Efficiency and biocompatibility of membranes. Contrib Nephrol. 1995;113:60-71. [PubMed ID: 7712723].

  • 9.

    Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW. Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol. 1993;3(7):1409-15. [PubMed ID: 8439653].

  • 10.

    Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, et al. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis. 1991;18(3):326-35. [PubMed ID: 1882824].

  • 11.

    Parker TF, 3rd, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int. 1996;49(2):551-6. [PubMed ID: 8821843]. https://doi.org/10.1038/ki.1996.78.

  • 12.

    Ikizler TA, Hakim RM. Nutrition in end-stage renal disease. Kidney Int. 1996;50(2):343-57. [PubMed ID: 8821843]. https://doi.org/10.1038/ki.1996.323.

  • 13.

    Pitcher WD, Diamond SM, Henrich WL. Pulmonary gas exchange during dialysis in patients with obstructive lung disease. Chest. 1989;96(5):1136-41. [PubMed ID: 2805844]. https://doi.org/10.1378/chest.96.5.1136.

  • 14.

    Hunt JM, Chappell TR, Henrich WL, Rubin LJ. Gas exchange during dialysis. Contrasting mechanisms contributing to comparable alterations with acetate and bicarbonate buffers. Am J Med. 1984;77(2):255-60. [PubMed ID: 6431811]. https://doi.org/10.1016/0002-9343(84)90700-9.

  • 15.

    Habte B, Carter R, Shamebo M, Veicht J, Boulton Jones JM. Dialysis induced hypoxemia. Clin Nephrol. 1982;18(3):120-5. [PubMed ID: 7140022].

  • 16.

    Knudsen F, Thorgaard Andersen P. Cellular hypoxia during hemodialysis. Demonstration of intradialytic release of purine and pyrimidine metabolites. Blood Purif. 1985;3(4):179-83. [PubMed ID: 3833259]. https://doi.org/10.1159/000169410.

  • 17.

    Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest. 1977;59(5):879-88. [PubMed ID: 856872]. https://doi.org/10.1172/JCI108710.

  • 18.

    Abu-Hamdan DK, Desai SG, Mahajan SK, Muller BF, Briggs WA, Lynne-Davies P, et al. Hypoxemia during hemodialysis using acetate versus bicarbonate dialysate. Am J Nephrol. 1984;4(4):248-53. [PubMed ID: 6433711]. https://doi.org/10.1159/000166818.

  • 19.

    Kao MT, Shiau YC, Tsai JJ, Wang JJ, Ho ST, Kao A. Evaluating the changes in alveolar permeability and lung ventilation in patients with chronic renal failure after haemodialysis using 99mTc-DTPA radioaerosol inhalation lung scan. Nucl Med Commun. 2003;24(7):825-8. [PubMed ID: 12813202]. https://doi.org/10.1097/00006231-200307000-00013.

  • 20.

    Kao MT, Shiau YC, Tsai JJ, Wang JJ, Ho ST, Kao A. Evaluating the changes in alveolar permeability and lung ventilation in patients with chronic renal failure after haemodialysis using 99mTc-DTPA radioaerosol inhalation lung scan. Nucl Med Commun. 2003;24(7):825-8. [PubMed ID: 12813202]. https://doi.org/10.1097/00006231-200307000-00013.

  • 21.

    Yap JC, Wang YT, Poh SC. Effect of oxygen on breathing irregularities during haemodialysis in patients with chronic uraemia. Eur Respir J. 1998;12(2):420-5. [PubMed ID: 9727795]. https://doi.org/10.1183/09031936.98.12020420.

  • 22.

    Fountain SW, Martin BA, Musclow CE, Cooper JD. Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits. Circ Res. 1980;46(2):175-80. [PubMed ID: 7351034]. https://doi.org/10.1161/01.RES.46.2.175.

  • 23.

    Ralph DD, Ott SM, Sherrard DJ, Hlastala MP. Inert gas analysis of ventilation-perfusion matching during hemodialysis. J Clin Invest. 1984;73(5):1385-91. [PubMed ID: 6715542]. https://doi.org/10.1172/JCI111342.

  • 24.

    Fawcett S, Hoenich NA, Laker MF, Schorr W, Jr, Ward MK, Kerr DN. Haemodialysis-induced respiratory changes. Nephrol Dial Transplant. 1987;2(3):161-8. [PubMed ID: 3114675].

  • 25.

    Vaziri ND, Wilson A, Mukai D, Darwish R, Rutz A, Hyatt J, et al. Dialysis hypoxemia. Role of dialyzer membrane and dialysate delivery system. Am J Med. 1984;77(5):828-33. [PubMed ID: 6496536]. https://doi.org/10.1016/0002-9343(84)90519-9.

  • 26.

    Hakim RM, Lowrie EG. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials. Nephron. 1982;32(1):32-9. [PubMed ID: 6817150]. https://doi.org/10.1159/000182728.